Details of the Drug
General Information of Drug (ID: DMOTXP1)
Drug Name |
Hydantocidin-5'-Monophosphate
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
Hydantocidin-5'-phosphate; HYDANTOCIDIN-5'-PHOSPHATE; PHOSPHOHYDANTOCIDIN; CHEMBL323799; H5P; 1juy; HYDANTOCIDIN-5'-MONOPHOSPHATE; 5'-phosphohydantocidin; AC1L9JTE; HYDANTOCIDIN-5''-PHOSPHATE; BDBM50149203; HYDANTOCIDIN-5''-MONOPHOSPHATE; DB02493; HNP; Phosphoric acid mono-((5S,7R,8S,9R)-8,9-dihydroxy-2,4-dioxo-6-oxa-1,3-diaza-spiro[44]non-7-ylmethyl) ester; [(1R,2S,3R,5S)-1,2-dihydroxy-6,8-dioxo-4-oxa-7,9-diazaspiro[44]nonan-3-yl]methyl dihydrogen phosphate; [(5S,7R,8S,9R)-8,9-dihydroxy-2,4-dioxo-6-oxa-1,3-diazaspiro[44]non-7-yl]methyl; Hydantocidin-5'-Phosphate
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 2 | Molecular Weight (mw) | 298.14 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | -4.4 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 6 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 9 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||